Clinical value of Epstein-Barr virus DNA levels in peripheral blood samples of Italian patients with Undifferentiated Carcinoma of Nasopharyngeal Type

Cancer Letters

Volumn 233, Issue 2, 2006, Pages 247-254

  Bortolin, Maria Teresa ^a   Pratesi, Chiara ^a   Dolcetti, Riccardo ^a   Bidoli, Ettore ^a   Vaccher, Emanuela ^a   Zanussi, Stefania ^a   Tedeschi, Rosamaria ^a   De Paoli, Paolo ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Epstein Barr virus; Real time PCR; Undifferentiated Carcinoma of Nasopharyngeal Type

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; MALE; NASOPHARYNX CARCINOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; UNDIFFERENTIATED CARCINOMA; VIREMIA; VIRUS LOAD;

ADULT; CARCINOMA; CASE-CONTROL STUDIES; COHORT STUDIES; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; ITALY; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; POLYMERASE CHAIN REACTION; VIRAL LOAD; VIRAL MATRIX PROTEINS; VIREMIA;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 33644655565     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.03.015     Document Type: Article

References (25)

1. J.P. Spano, P. Busson, D. Atlan, J. Bourhis, J.P. Pignon, C. Esteban, and J.P. Armand Nasopharyngeal carcinomas: an update Eur. J. Cancer 39 2003 2121 2135
2. S. Kondo, T. Horikawa, H. Takeshita, C. Kanegane, Y. Kasahara, and T.S. Sheen Diagnostic value of serum EBV-DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patients Cancer Sci. 95 2004 508 513
3. G. Franchin, E. Vaccher, R. Talamini, C. Gobitti, E. Minatel, and D. Politi Nasopharyngeal cancer WHO type II-III: monoinstitutional retrospective analysis with standard and accelerated hyperfractionated radiation therapy Oral Oncol. 38 2002 137 144
4. P. Busson, C. Keryer, T. Ooka, and M. Corbex EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies Trends Microbiol. 12 2004 356 360
5. Y.M. Lo Prognostic implication of pre-treatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinoma Biomed. Pharmacother. 55 2001 362 365
6. J.C. Lin, W.Y. Wang, K.Y. Chen, Y.H. Wei, W.M. Liang, J.S. Jan, and R.S. Jiang Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N. Engl. J. Med. 350 2004 2461 2470
7. R.L. Hong, C.Y. Lin, L.L. Ting, J.Y. Ko, and M.M. Hsu Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA Cancer 100 2004 1429 1437
8. S.F. Leung, A.T. Chan, B. Zee, B. Ma, L.Y. Chan, P.J. Johnson, and Y.M. Lo Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early stage nasopharyngeal carcinoma of undifferentiated type Cancer 98 2003 288 291
9. E.W. To, K.C. Chan, S.F. Leung, L.Y. Chan, K.F. To, and A.T. Chan Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma Clin. Cancer Res. 9 2003 3254 3259
10. J.C. Lin, K.Y. Chen, W.Y. Wang, J.S. Jan, W.M. Liang, C.S. Tsai, and Y.H. Wei Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival J. Clin. Oncol. 19 2001 2607 2615
11. S.J. Stevens, S.A. Verkuijlen, A.J. Brule, and J.M. Middeldorp Comparison of quantitative competitive PCR with LightCycler-based PCR for measuring Epstein-Barr virus DNA load in clinical specimens J. Clin. Microbiol. 40 2002 3986 3992
12. J. Jebbink, X. Bai, B.B. Rogers, D.B. Dawson, R.H. Scheuermann, and R. Domiati-Saad Development of real-time PCR assays for the quantitative detection of Epstein-Barr virus and cytomegalovirus, comparison of TaqMan probes, and molecular beacons J. Mol. Diagn. 5 2003 15 20
13. R.M. Wadowsky, S. Laus, M. Green, S.A. Webber, and D. Rowe Measurement of Epstein-Barr virus DNA loads in whole blood and plasma by TaqMan PCR and in peripheral blood lymphocytes by competitive PCR J. Clin. Microbiol. 41 2003 5245 5249
14. S. Maurmann, L. Fricke, H.J. Wagner, P. Schlenke, H. Henning, J. Steinhoff, and W.J. Jabs Molecular parameters for precise diagnosis of asympomatic Epstein-Barr virus reactivation in healthy carriers J. Clin. Microbiol. 41 2003 5419 5428
15. C. Pratesi, M.T. Bortolin, M. D'Andrea, E. Vaccher, L. Barzan, and E. Bidoli Quantitative plasma/serum EBV DNA load by LMP2A determination in an Italian cohort of NPC patients J. Clin. Virol. 28 2003 155 164
16. K. Brengel-Pesce, P. Morand, A. Schmuck, M.J. Bourgeat, M. Buisson, and G. Bargues Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections J. Med. Virol. 66 2002 360 369
17. A. Mutirangura Serum/plasma viral DNA: mechanisms and diagnostic applications to nasopharyngeal and cervical carcinoma Ann. N. Y. Acad. Sci. 945 2001 59 67
18. S.J. Stevens, I. Pronk, and J.M. Middeldorp Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen J. Clin. Microbiol. 39 2001 1211 1216
19. R. Tedeschi, M. Enbom, E. Bidoli, A. Linde, P. De Paoli, and J. Dillner Viral load of human herpesvirus eight in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma J. Clin. Microbiol. 39 2001 4269 4273
20. U. O'Doherty, W.J. Swiggard, D. Jeyakumar, D. McGain, and M.H. Malim A sensitive, quantitative assay for human immunodeficiency virus type 1 integration J. Virol. 76 2002 10942 10950
21. A. Dehee, C. Asselot, T. Piolot, C. Jacomet, W. Rozenbaum, and M. Vidaud Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR J. Med. Virol. 65 2001 543 552
22. B.G. Fanson, P. Osmack, and A.M. Di Bisceglie A comparison between the phenol-chloroform method of RNA extraction and the QIAamp viral RNA kit in the extraction of hepatitis C and GB virus-C/hepatitis G viral RNA from serum J. Virol. Methods 89 2000 23 27
23. A. Widschwendter, A. Blassnig, A. Wiedemair, E. Muller-Holzner, H.M. Muller, and C. Marth Human papillomavirus DNA in sera of cervical cancer patients as tumor marker Cancer Lett. 202 2003 231 239
24. S. Fafi-Kremer, K. Brengel-Pesce, G. Barguès, M.J. Bourgeat, O. Genoulaz, J.M. Seigneurin, and P. Morand Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma J. Clin. Virol. 30 2004 157 164
25. J.Y. Shao, Y. Zhang, Y.H. Li, H.Y. Gao, H.X. Feng, and Q.L. Wu Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma Anticancer Res. 24 2004 4059 4066